. 2021 Oct 28;2021:9972386. doi: 10.1155/2021/9972386

Table 13.

Double selection.

	HbA1c < 6.5%	Hypoglycemia	Endpoint HRQoL	Inpatient cost	Outpatient cost	OTC drug cost	Total cost
Metformin	0.33^a	0.35^a	0.89^ab	4.13^b	3.46^ab	0.86^a	8.34^bc
Metformin	(0.03)	(0.05)	(0.01)	(0.92)	(0.28)	(0.12)	(1.00)
Xiaoke Pill	0.44^b	0.42^a	0.90^b	1.38^a	2.86^a	0.81^a	5.04^a
Xiaoke Pill	(0.03)	(0.05)	(0.01)	(0.89)	(0.27)	(0.11)	(0.97)
Other TCMs	0.35^ab	0.48^a	0.89^ab	3.34^ab	3.80^bc	1.53^b	8.84^bc
Other TCMs	(0.04)	(0.07)	(0.01)	(1.19)	(0.36)	(0.15)	(1.29)
Gliclazide	0.41^ab	0.42^a	0.87^ab	2.16^ab	3.82^bc	0.80^a	6.82^abc
Gliclazide	(0.04)	(0.07)	(0.01)	(1.19)	(0.37)	(0.15)	(1.30)
Acarbose	0.40^ab	0.39^a	0.88^ab	4.37^ab	4.74^cd	1.18^ab	10.24^c
Acarbose	(0.04)	(0.07)	(0.01)	(1.26)	(0.39)	(0.16)	(1.37)
Xiaoke Pill+	0.44^b	0.37^a	0.87^a	1.95^ab	3.38^ab	0.85^a	5.95^ab
Xiaoke Pill+	(0.03)	(0.06)	(0.01)	(1.01)	(0.31)	(0.13)	(1.09)
Glibenclamide	0.32^ab	0.42^a	0.89^ab	0.95^ab	3.26^abcd	0.34^a	4.07^abc
Glibenclamide	(0.12)	(0.22)	(0.03)	(3.77)	(1.16)	(0.48)	(4.10)
Others	0.36^ab	0.44^a	0.89^ab	3.16^ab	5.09^d	0.87^a	9.17^c
Others	(0.01)	(0.03)	(0.00)	(0.45)	(0.14)	(0.06)	(0.48)

Observations	1903	1903	1903	1903	1903	1903	1903

Note: inpatient cost, outpatient cost, medication cost, and total cost are measured with the unit of 1000 RMB. The predictive margins are calculated after multivariate regressions. When calculating the predictive margins, covariates including age, sex, education, household income, type of medical insurance, city of residence, diabetes-related morbidities including AMI, hypertension, dyslipidemia, and stroke, duration of diabetes, alcoholic use, smoking, physical exercise, diet control, BMI, blood glucose level, HbA1c, blood pressure, TCH, TG, and EQ-5D score are controlled. Estimates sharing a letter in the group label are not significantly different at the 5% level.